University of Cambridge > > Sensors CDT seminars > The Evolution of PolyProx Therapeutics

The Evolution of PolyProx Therapeutics

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Karen Scrivener.

Laura Itzhaki’s talk will focus on a new technology that PolyProx Therapeutics has developed to harness the cell’s internal quality-control machinery. Their approach shortcuts cell signals to redirect the machinery to dispose of disease-associated proteins. In 2019, PolyProx Therapeutics secured seed financing to develop drug candidates exploiting this technology.

This talk is part of the Sensors CDT seminars series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity